Michael King: Oncology Drug Development Builds Biotech Wealth
PublishedMarch 19, 2014
Michael King: Oncology Drug Development Builds Biotech Wealth
Veteran biotechnology analyst Michael King of JMP Securities has seen drug development evolve from hit-or-miss to the sophisticated, high-throughput discovery techniques in place today. He understands … That is why an Epizyme or a Karyopharm, in my … Read more on Kapitall Blog (blog)
North Penn Life Community Calendar: Week of March 16
Through the spring, there will be free, public Herb Gatherers programs at 7 p.m. at the Bethel Hill United Methodist Church 2000 Bethel Hill Road, Lansdale. The programs include: • April 14: Linda Shanahan, RN, of Doylestown Hospice, will …. call 215 … Read more on Montgomery Newspapers
Fearing 'wave of addiction,' Rogers hopes to overturn FDA approval of new …
The drug helped drive a staggering 296 percent increase in overdose deaths in Kentucky from 2000 to 2010. Lawmakers, police and some treatment providers fear a repeat with the current form of Zohydro. "There's … U.S. Sen. Joe Manchin, a Democrat from … Read more on The Messenger (subscription)
addiction hotline help — Calling an addiction hotline is one of the easiest ways to inquire about treatment options and locate rehabilitation facilities near you,G96dl1STU7. One of t…